(Q48360876)

11 February 2018

title

Food and Drug Administration (FDA) drug approval end points for chronic cutaneous ulcer studies. (English)

1 reference

11 February 2018

2

Robert S Kirsner

1 reference

11 February 2018

author name string

William H Eaglstein

series ordinal

1

1 reference

11 February 2018

Martin C Robson

series ordinal

3

1 reference

11 February 2018

publication date

1 November 2012

1 reference

11 February 2018

Wound Repair and Regeneration

published in

1 reference

11 February 2018

volume

20

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

page(s)

793-796

1 reference

11 February 2018

Human skin wounds: a major and snowballing threat to public health and the economy

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00849.X

History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trøndelag Health Study, Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00849.X

High mortality in patients with chronic wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00849.X

The problem of pressure sores in a nursing home population: statistical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00849.X

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00849.X

Spectrum of cancer risk among US solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00849.X

Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00849.X

Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00849.X

Wound-healing trajectories as outcome measures of venous stasis ulcer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00849.X

Surrogate endpoints for the treatment of venous leg ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00849.X

Original articles: ease of wound closure as an endpoint of treatment efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00849.X

Defining success in clinical trials of diabetic foot wounds: the Los Angeles DFCon consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00849.X

Five-year follow-up of a cohort of people with their first diabetic foot ulcer: the persistent effect of depression on mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00849.X

The Safety and Effect of Topically Applied Recombinant Basic Fibroblast Growth Factor on the Healing of Chronic Pressure Sores

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00849.X

10.1111/J.1524-475X.2012.00849.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

23126458

1 reference

11 February 2018